Page last updated: 2024-09-03

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Bone Diseases, Metabolic

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, JU; Kang, SS; Kim, JS; Kim, SB; Kim, YJ; Lee, HK1

Other Studies

1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Bone Diseases, Metabolic

ArticleYear
Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
    Clinical nephrology, 2010, Volume: 74, Issue:5

    Topics: Absorptiometry, Photon; Alkaline Phosphatase; Biomarkers; Body Mass Index; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Calcifediol; Chronic Disease; Collagen Type I; Cross-Sectional Studies; Female; Femur Neck; Humans; Kidney Diseases; Linear Models; Lumbar Vertebrae; Male; Middle Aged; Nutritional Status; Oligopeptides; Osteocalcin; Parathyroid Hormone; Peptide Fragments; Peptides; Peritoneal Dialysis; Prealbumin; Protein Precursors; Republic of Korea; Time Factors

2010